Tumor Antigen Discovery by LCMS/MS
Based on our 30+ years world-class experience in proteomic analysis, our Tumor Antigen Discovery platform can de novo identify tumor specific antigens, across entire cancer genome, with many different types of mutations in cancer cells. More
Based on our 30+ years world-class experience in proteomic analysis, our Tumor Antigen Discovery platform can de novo identify tumor specific antigens, across entire cancer genome, with many different types of mutations in cancer cells. More
Antibody De Novo Sequencing
With our state-of-the-art antibody de novo sequencing technology, we assure our clients of 100% accuracy in the delivered antibody sequences...More
With our state-of-the-art antibody de novo sequencing technology, we assure our clients of 100% accuracy in the delivered antibody sequences...More
Protein Characterization
complete analysis of protein primary structure, N- and C-terminals, disulfide bond linkage, etc…More
complete analysis of protein primary structure, N- and C-terminals, disulfide bond linkage, etc…More
Protein Identification & Analysis
Ultra-sensitive NanoLC-MS technique to identify proteins from the gel, solution or complex mixture, etc… Our turn around time is five business days.More
Ultra-sensitive NanoLC-MS technique to identify proteins from the gel, solution or complex mixture, etc… Our turn around time is five business days.More
Protein Mutation & Sequence Variant Analysis
Analyzing protein mutations to obtain complete sequence of a mutated protein…More
Analyzing protein mutations to obtain complete sequence of a mutated protein…More